Montant estimatif des distributions annuelles des gains en capital réinvestis des fonds négociés en bourse de Gestion d’actif JPMorgan (Canada) inc. pour 2024
02. Dezember 2024 17:24 ET
|
JPMorgan Asset Management (Canada) Inc.
TORONTO, 02 déc. 2024 (GLOBE NEWSWIRE) -- J.P. Morgan Asset Management (JPMAM)* a annoncé aujourd’hui les montants estimatifs des distributions annuelles des gains en capital réinvestis pour...
JPMorgan Asset Management (Canada) Inc. Exchange Traded Funds 2024 Estimated Annual Reinvested Capital Gain Distributions
02. Dezember 2024 17:24 ET
|
JPMorgan Asset Management (Canada) Inc.
TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- J.P. Morgan Asset Management (JPMAM)* today announced the estimated annual reinvested capital gain distributions for the below listed JPMorgan ETFs (the...
JPMorgan annonce des distributions en espèces pour les FNB JPMorgan
25. November 2024 07:00 ET
|
JPMorgan Asset Management (Canada) Inc.
TORONTO, 25 nov. 2024 (GLOBE NEWSWIRE) -- J. P. Morgan Asset Management (JPMAM)* a annoncé aujourd’hui les montants définitifs des distributions en espèces de novembre 2024 pour les FNB JPMorgan...
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
25. November 2024 07:00 ET
|
JPMorgan Asset Management (Canada) Inc.
TORONTO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- J. P. Morgan Asset Management (JPMAM)* today announced the final November 2024 cash distributions for the below listed JPMorgan ETFs. The JPMorgan ETFs...
Announcement Potential Entering of Distribution Agreement with CICC and JPMorgan
13. September 2024 05:28 ET
|
Garden stage Limited
Hong Kong, Sept. 13, 2024 (GLOBE NEWSWIRE) -- I Win Securities Limited (“I Win”), a wholly-owned subsidiaries of Garden Stage Limited (NASDAQ: GSIW) (“Garden Stage”), has been in advanced...
Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index
29. Juli 2024 08:30 ET
|
Carmell Corporation
Carmell Corp (Nasdaq: CTCX) announced the appointment of Kendra Bracken-Ferguson as CEO effective July 30, 2024 with Rajiv Shukla continuing as Chairman.
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
07. Januar 2024 12:00 ET
|
Exagen Inc.
CARLSBAD, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announces select preliminary unaudited financial results for...
ExCellThera rencontrera les investisseurs durant la 42e conférence annuelle J.P. Morgan Healthcare et participera aux prochaines conférences d'investisseurs
02. Januar 2024 07:00 ET
|
ExCellThera
MONTREAL, 02 janv. 2024 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), un leader mondial des thérapies à base de cellules souches sanguines amplifiées, a annoncé aujourd'hui que ses hauts...
ExCellThera to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference and to Participate in Upcoming Investor Conferences
02. Januar 2024 07:00 ET
|
ExCellThera
ExCellThera senior leaders will be holding investor meetings during JP Morgan Heathcare Conference and participating in upcoming investor conferences.
ITM to Present at the 42nd Annual J.P. Morgan Healthcare Conference
21. Dezember 2023 08:00 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, Germany, December 21, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that CEO, Steffen Schuster and CFO, Dr. Klaus...